A Houston-area company has created an easy-to-use health-check app for employees returning to work. Pexels

A Woodlands-based health services company recently announced a new app that can serve as a self-service pre-screening tool for COVID-19 to be used by employees to return to their workplace.

Axiom Medical created the CheckIn2Work app to make the transition into the workplace after the coronavirus crisis safer and easier, making it simple for businesses and offices to reopen after stay-at-home orders shut down workplaces during the height of the pandemic.

"Given the current challenges we have all experienced with COVID-19, we recognize the workplace will be forever changed," says Axiom Medical President and CEO Mark Robinson. "Our CheckIn2Work app simply adds another layer to protecting the health of team members, customers, and vendors from the risk of infectious disease in the workplace."

The app includes features such as a 24/7 self-service illness screening with the latest screening criteria approved by Chief Medical Officer Scott Cherry. The app also includes immediate access to U.S.-based Clearance Center for exposure/illness alerts, real-time reporting, and ongoing best practices to reduce the spread of the virus in the work environment.

When an app user is flagged as exposed to the virus, Axiom Medical's Rapid Response Contagious Respiratory Illness Assessment Clearance Center professionals can conduct secondary screening procedures via a phone call to confirm cases and eliminate false positives.

The app has 50,000 users already from Axiom's new and existing clients who have signed on to the platform. Some of their partners include BJ Services, Tyson Foods, ISS Facility Services, and Fort Bend Kia, Robinson says it creates safe and healthy facilities for both employees and customers.

"It enables our clients to be appropriately responsive to trying to screen out the infection in their workplace," says Robinson, "It also gives employees confidence that returning to work and exposing themselves to their coworkers is safe while providing customers who have contact with the employees with the confidence who they will be interacting with has been screened and cleared."

For the health services company, keeping employees safe has been the heart of their mission since it was founded more than two decades ago. Axiom Medical markets itself as an employer's outsourced "in house" medical department, managing a complete array of occupational health services such as scheduling exams, verifying results for accuracy, and maintaining records.

"Our focus is on the health of the worker in the workplace," says Robinson. "Both our traditional services and our new service all focus on keeping people as healthy as possible, returning them to work as quickly as possible after an injury or illness keeps them out of the workplace, and making sure they are tested for a variety of risks."

CheckIn2Work is now available on iOS and Android mobile devices including a web portal where employees can check in before work every day to check for symptoms of COVID-19. The app is adaptable with language settings in English and Spanish and allows for customizable questions to fit an organization's needs.

"I hope we can continue to take this seriously and take good precautions," says Robinson. "This is a really horrible disease, it isn't just about the people who die as a result, it's also about those who are permanently disabled because of it. Those weeks in a hospital are mirrored by more weeks in recovery before they can even think about working again."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Meta to bring $115 million AI data center training initiative to Houston

ai workforce

Meta and Associated Builders and Contractors have entered into a partnership to invest $115 million in training programs for the construction of AI data centers, with a portion of the project launching in Houston.

The companies announced June 8 that they would open America’s Workforce Academies at ABC chapter training centers in Houston; Indianapolis; Baton Rouge, Louisiana; and Columbus, Ohio.

The academies will offer career readiness and safety training, plus five weeks of hands-on education. Participants who complete the program will be granted a job offer from contractors working on Meta projects.

“The AI revolution is bringing change but also historic opportunities,” Dina Powell McCormick, Meta president and vice-chairman, said in a news release. “Skilled workers electrified rural America one pole at a time. They manned the factories that built the arsenal that won World War II. Now a new generation will pour the foundations and lay the fiber that secures American strength in this new age.”

Overall, the Meta and ABC aim for the academies to build a more sustainable pipeline of skilled construction workers and ensure safety and job readiness for the surging number of data center projects underway.

“This new program is an innovative talent solution that is a critical part of addressing the construction industry’s ongoing workforce shortage and creates an accelerated, new-entrant strategy for job seekers ... The sustained demand for data center construction technicians means the industry needs an all-of-the-above approach to address this shortage and grow the construction talent pool,” Michael Bellaman, ABC president and CEO, added in the release.

In Texas, Meta, the parent company of Facebook and Instagram, has launched or broken ground on data centers in El Paso, Fort Worth and Temple. The company announced in March that it planned to grow its El Paso Data center by 1 gigawatt, representing more than a $10 billion investment.

Apart from Meta, Texas has attracted data center development to power other giants like Google and Amazon in recent years. In turn, Texas has been predicted to become the biggest data center market. Commercial real estate services provider JLL reported this spring that the state could topple Northern Virginia as the world’s largest data-center market by 2030. Similarly, CBRE predicted that Houston's data center capacity could double by 2028. Read more here.

New Houston biotech co. lands $30M for pulmonary fibrosis drug

drug money

Most of us can claim a scar or two on our bodies. But when scarring develops inside the body, it’s known as a fibrotic disorder. A freshly launched Houston company, Oorja Bio Inc., is working on a treatment that can help to repair cells and reduce the damage wrought by the growth of fibrotic tissue in patients.

Late last month, Oorja Bio hit the scene with a pair of big announcements. Not only has the company raised a $30 million Series A thanks to founding investor California-based Westlake BioPartners, but it has also already paved the way for a Phase 2 study to take place this year.

Oorja Bio received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to test its treatment in patients with idiopathic pulmonary fibrosis (IPF), a scarring of the lung tissue. IPF affects more than 150,000 adults in the United States and can result in a range of symptoms from shortness of breath to organ failure and death as it progresses.

Oorja Bio’s lead drug candidate, ORJ-001, was shown in a Phase 1 in-human trial to demonstrate “therapeutically relevant exposure and favorable tolerability” in 64 healthy adult volunteers in whom it was administered daily or weekly, according to a news release. Pre-clinical studies of ORJ-001 showed durable target tissue engagement and biomarker activity in bleomycin-induced lung fibrosis.

Administered subcutaneously, ORJ-001 is intended to improve and even restore function in cells that can reduce the signaling that causes IPF. It stops advancement of IPF and also allows for tissue repair. Currently available treatments for the disease can slow the development of IPF down, but do not address the declining lung function that’s inherent in its progression.

“The clinical and preclinical results from our studies to date give us confidence that ORJ-001 represents a novel treatment approach with the potential to repair and reverse fibrosis and modify disease progression in IPF,” Dr. Janethe Pena, CMO of Oorja Bio, said in the release.

“Our team is energized to deliver on our goal of redefining the future of fibrotic diseases, beginning with ORJ-001,” CEO and founder Sujay Kango added. “As we advance ORJ-001 in the clinic, we are embracing the paradigm shift in our biological understanding of IPF pathology that aligns with the central role of the alveolar epithelium. ORJ-001 was designed with this biology in mind and may provide, for the first time, a therapeutic intervention that repairs and reverses fibrosis and promotes disease modification.”

Most patients live only three to five years following their IPF diagnosis. Soon, ORJ-001 and Oorja Bio could give them a fighting chance.

Axiom Space tops $525M in oversubscribed round, announces Swiss subsidiary

funding boost

Axiom Space tacked on an additional $175 million to a previously announced capital raise, bringing the oversubscribed round to a total of more than $525 million.

Axiom shared in February that it had secured $350 million in a financing round led by Type One Ventures and Qatar Investment Authority. In the latest release from the company, Axiom reports that Japan-based MUFG Bank Ltd. joined the round as a new investor, in addition to continued participation from existing backers.

The funding will go toward developing the company's commercial space station, known as Axiom Station, and the production of its Axiom Extravehicular Mobility Unit (AxEMU) under its NASA spacesuit contract.

“Investor interest in this round outpaced what we set out to raise, which speaks to the moment we’re in,” Jonathan Cirtain, CEO and president of Axiom Space, said in the news release. “Our partners see what is possible in low-Earth orbit, and they see who is positioned to lead it.”

Axiom announced last month that it planned to open a Japanese subsidiary July 1. Earlier this week, it also shared plans to establish Axiom Space Switzerland, a wholly owned subsidiary based in Lucerne that is also expected to begin operations this summer.

The Switzerland subsidiary aims to establish Axiom's presence in Europe and help it partner with the European Space Agency and other space organizations and companies on the continent.

“Europe is a founding leader in the creation of the commercial space economy, and Switzerland is uniquely positioned to convene the government agencies, research institutions, and industrial entities that will shape its next decade,” Cirtain added in a separate release. “Axiom Space Switzerland facilitates the scaling of development and deployment of the infrastructure that will succeed the International Space Station.”